Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 3
2000 9
2001 10
2002 25
2003 28
2004 35
2005 48
2006 65
2007 96
2008 60
2009 79
2010 67
2011 84
2012 90
2013 84
2014 70
2015 77
2016 73
2017 75
2018 69
2019 53
2020 64
2021 69
2022 68
2023 52
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

1,318 results

Results by year

Filters applied: . Clear all
Page 1
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Yatham LN, et al. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. Bipolar Disord. 2018. PMID: 29536616 Free PMC article.
First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, lurasidone, or adjunctive lamotrigine. ...In addition to addressing issues in bipolar I disorder, these guidelines also provide an ove …
First-line options for bipolar I depression include quetiapine, lurasidone plus lithium or divalproex, lithium, lamotrigine, l …
Quetiapine monotherapy for bipolar depression.
Janicak PG, Rado JT. Janicak PG, et al. Expert Opin Pharmacother. 2011 Jul;12(10):1643-51. doi: 10.1517/14656566.2011.585461. Epub 2011 May 24. Expert Opin Pharmacother. 2011. PMID: 21609188 Review.
AREAS COVERED: The article examines the mechanism of action and pharmacokinetics of quetiapine, its evidence base as a treatment for bipolar depression and related issues of safety and tolerability. EXPERT OPINION: In the context of bipolar disorder, queti
AREAS COVERED: The article examines the mechanism of action and pharmacokinetics of quetiapine, its evidence base as a treatment for …
Quetiapine for acute bipolar depression: a systematic review and meta-analysis.
Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Suttajit S, et al. Drug Des Devel Ther. 2014 Jun 25;8:827-38. doi: 10.2147/DDDT.S63779. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25028535 Free PMC article. Review.
BACKGROUND: Precise estimated risks and benefits of quetiapine for acute bipolar depression are needed for clinical practice. ...CONCLUSION: Quetiapine monotherapy is effective for acute bipolar depression and the prevention of mania/hypomania switchin …
BACKGROUND: Precise estimated risks and benefits of quetiapine for acute bipolar depression are needed for clinical practice. …
Comparison of the efficacy and safety of quetiapine and lithium for bipolar depression: A systematic review and meta-analysis of randomized controlled trials.
Ogasawara M, Takeshima M, Esaki Y, Kaneko Y, Utsumi T, Aoki Y, Watanabe N, Suzuki M, Takaesu Y. Ogasawara M, et al. Neuropsychopharmacol Rep. 2022 Dec;42(4):410-420. doi: 10.1002/npr2.12283. Epub 2022 Jul 20. Neuropsychopharmacol Rep. 2022. PMID: 35858678 Free PMC article. Review.
CONCLUSION: Although this study found no differences in the efficacy and safety of quetiapine and lithium for bipolar depression, a comprehensive comparison of antipsychotics and mood stabilizers was not performed. Further studies are needed to clarify which of thes …
CONCLUSION: Although this study found no differences in the efficacy and safety of quetiapine and lithium for bipolar depressi …
A Randomized, Double-Blind, Controlled Trial of Lithium Versus Quetiapine for the Treatment of Acute Mania in Youth with Early Course Bipolar Disorder.
Patino LR, Klein CC, Strawn JR, Blom TJ, Tallman MJ, Adler CM, Welge JA, DelBello MP. Patino LR, et al. J Child Adolesc Psychopharmacol. 2021 Sep;31(7):485-493. doi: 10.1089/cap.2021.0039. Epub 2021 Sep 14. J Child Adolesc Psychopharmacol. 2021. PMID: 34520250 Free PMC article. Clinical Trial.
Objective: To compare the efficacy and tolerability of lithium versus quetiapine for the treatment of manic or mixed episodes in youths with early course bipolar I disorder. ...Results: A total of 109 patients were randomized (quetiapine = 58 and lithium = 51 …
Objective: To compare the efficacy and tolerability of lithium versus quetiapine for the treatment of manic or mixed episodes in yout …
Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.
Ketter TA, Miller S, Dell'Osso B, Wang PW. Ketter TA, et al. J Affect Disord. 2016 Feb;191:256-73. doi: 10.1016/j.jad.2015.11.002. Epub 2015 Nov 25. J Affect Disord. 2016. PMID: 26688495 Review.
Completion of Bipolar CHOICE offers a timely opportunity to review the evidence regarding lithium and quetiapine for bipolar disorder. ...Combination therapy including quetiapine and lithium was generally more effective than either agent alone in acute …
Completion of Bipolar CHOICE offers a timely opportunity to review the evidence regarding lithium and quetiapine for bipola
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Nomura I, Hatano M, Iwata N. Kishi T, et al. Mol Psychiatry. 2022 Feb;27(2):1136-1144. doi: 10.1038/s41380-021-01334-4. Epub 2021 Oct 12. Mol Psychiatry. 2022. PMID: 34642461 Free PMC article.
Compared with the placebo, aripiprazole, asenapine, carbamazepine, cariprazine, haloperidol, lithium, olanzapine, paliperidone, quetiapine, risperidone, tamoxifen, valproate, and ziprasidone outperformed response to treatment (N = 56, n = 14503); aripiprazole, olanzapine, …
Compared with the placebo, aripiprazole, asenapine, carbamazepine, cariprazine, haloperidol, lithium, olanzapine, paliperidone, quetiapin
The role of quetiapine in the treatment of bipolar disorder.
Pini S, Abelli M, Cassano GB. Pini S, et al. Expert Opin Pharmacother. 2006 May;7(7):929-40. doi: 10.1517/14656566.7.7.929. Expert Opin Pharmacother. 2006. PMID: 16634715 Review.
Through a review of randomised, controlled trials, this article evaluates the efficacy and tolerability of quetiapine in the acute and maintenance phases of bipolar disorder. ...With regard to the prevention of relapses in bipolar disorder, quetiapine
Through a review of randomised, controlled trials, this article evaluates the efficacy and tolerability of quetiapine in the acute an …
Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review.
Roosen L, Sienaert P. Roosen L, et al. J Affect Disord. 2022 Aug 15;311:69-77. doi: 10.1016/j.jad.2022.05.017. Epub 2022 May 8. J Affect Disord. 2022. PMID: 35545157 Review.
Randomized controlled trials including at least 10 patients with bipolar disorder, rapid cycling, reporting an objective outcome measure were selected. ...Lithium, anticonvulsants, second generation antipsychotics, antidepressants and thyroid hormone were assessed as treat …
Randomized controlled trials including at least 10 patients with bipolar disorder, rapid cycling, reporting an objective outcome meas …
Quetiapine extended release for the treatment of bipolar disorder.
Samalin L, Tremey A, Llorca PM. Samalin L, et al. Expert Rev Neurother. 2014 Sep;14(9):987-1005. doi: 10.1586/14737175.2014.946407. Epub 2014 Aug 6. Expert Rev Neurother. 2014. PMID: 25096854 Review.
Over recent decades the therapeutic arsenal for BD has expanded to include lithium, anticonvulsants and second-generation antipsychotics (SGAs). Immediate release (IR) quetiapine fumarate is a SGA approved in several countries for the treatment of patients with schi …
Over recent decades the therapeutic arsenal for BD has expanded to include lithium, anticonvulsants and second-generation antipsychotics (SG …
1,318 results